As one of the most trusted global pharmaceutical manufacturers, Taj Medico continues to strengthen its footprint across the Philippines and broader APAC region, offering world-class formulations, robust regulatory dossiers, and high-capacity manufacturing aligned with WHO-GMP, PIC/S, and ISO 9001:2018 standards.

Our expanding product basket includes next-generation therapeutics across diabetes, cardiology, gastroenterology, neuropathy, and hepatology, backed by complete regulatory support for fast-track registration.


Comprehensive APAC Product Portfolio

Regulatory-Ready Portfolio for Fast Market Entry

Below is the detailed table requested:

Product NameTherapeutic CategoryACTD DossiersCOPPBCS Class
Semaglutide 3 / 7 / 14 mg TabletAntidiabetic (GLP-1 RA)Ready/Under DevelopmentAvailableClass III
Dapagliflozin + Sitagliptin + Metformin (5/50/500 mg & 10/100/1000 mg)Antidiabetic (SGLT2i + DPP4i + Metformin)ReadyAvailableClass III
Pregabalin 75 mg + Benfotiamine 300 mg + Alpha Lipoic Acid 300 mg + Methylcobalamin 0.75 mg TabletNeuropathic PainReadyAvailableClass II / III
Bexagliflozin 20 mg TabletAntidiabetic (SGLT2i)ReadyAvailableClass I
Sotagliflozin 200 mg & 400 mg TabletDual SGLT1/2 InhibitorReady/Under DevelopmentOn RequestClass I
Bexagliflozin + Metformin TabletAntidiabetic (Fixed Dose Combination)Under DevelopmentOn RequestClass I / III
Sotagliflozin + Metformin TabletAntidiabetic (FDC)Under DevelopmentOn RequestClass I / III
Tegoprazan 50 mg TabletGastric Acid Suppressant (P-CAB)ReadyAvailableClass I
Zastaprazan 20 mg TabletP-CAB (Gastroenterology)Under DevelopmentOn RequestClass I
Obeticholic Acid 5 mg / 10 mg TabletHepatology (PBC)ReadyAvailableClass II
Agomelatine 25 mg TabletAntidepressant (Melatonergic)ReadyAvailableClass II

Taj Medico’s Leadership in the Philippine & APAC Pharmaceutical Landscape

A Growing Demand for High-Quality, WHO-GMP Compliant Products

Across the APAC region—particularly the Philippines, Vietnam, Cambodia, Indonesia, and Myanmar—regulators increasingly demand trusted international manufacturers with stringent compliance systems. Taj Medico addresses this demand through:

  • End-to-end ACTD dossier support
  • WHO-GMP, PIC/S, GLP certified facilities
  • Fast-track COPP issuance for priority products
  • Robust QMS aligned with global regulatory expectations
  • Regulatory, technical, and commercial partnership models

This ensures healthcare authorities and distributors in the APAC region receive consistent quality, regulatory reliability, and competitive pricing, setting Taj Medico apart as a preferred supplier.


High-Value Products Driving Strong Market Growth

1. Advanced Diabetes Portfolio Empowering APAC Healthcare Systems

The APAC region faces one of the world’s fastest-growing diabetes populations, elevating demand for modern oral antidiabetics such as GLP-1 receptor agonists, SGLT2 inhibitors, and DPP4 inhibitors.

Semaglutide Tablets (3 / 7 / 14 mg)

A breakthrough in Type 2 diabetes management, Semaglutide oral tablets offer improved glycemic control and weight management. Taj Medico is among few with:

  • Scaled production capability
  • ACTD dossier support
  • Stability Zone IVB data

Bexagliflozin 20 mg & Sotagliflozin 200/400 mg

These next-generation SGLT2 inhibitors deliver:

  • Lower HbA1c
  • Cardiovascular benefits
  • Superior tolerability profiles

With large-scale SGLT2 manufacturing expertise, Taj Medico brings cost-effective, high-quality alternatives to APAC markets.

Triple Combination Antidiabetic Tablet

Dapagliflozin + Sitagliptin + Metformin offers:

  • Multi-pathway glycemic control
  • High patient compliance
  • Strong commercial potential in APAC markets

2. Neuropathy Segment: Complete FDC Solutions

The combination of Pregabalin + Benfotiamine + Alpha Lipoic Acid + Methylcobalamin addresses diabetic neuropathy with a multi-therapeutic approach and remains a top-imported segment in the Philippines, giving Taj Medico a strong commercial advantage.


3. Gastroenterology Excellence: P-CAB Leadership

Tegoprazan 50 mg & Zastaprazan 20 mg

P-CABs represent the next era of acid suppression therapy, outperforming PPIs in:

  • Faster onset of action
  • Better night-time acid control
  • Improved ulcer healing efficacy

Their growing market adoption in Korea, Japan, and now the Philippines positions Taj Medico as a strategic early entrant.


4. Liver Disease Therapies for Growing APAC Demand

Obeticholic Acid (5 mg / 10 mg)

Used for Primary Biliary Cholangitis (PBC), this specialized hepatology product is seeing increasing demand across APAC due to rising liver disease prevalence.

Taj Medico supports:

  • Full ACTD/CTD documentation
  • Bioequivalence support
  • Long-term stability data

5. Psychiatry & CNS Care

Agomelatine 25 mg Tablet

A unique melatonergic antidepressant with a low side-effect profile, perfectly aligned with rising mental health priorities across APAC healthcare systems.


Why Taj Medico Leads the APAC Regulatory & Supply Chain Ecosystem

Strong Regulatory Infrastructure

We provide:

  • ACTD-ready dossiers for major APAC markets
  • Bioequivalence support
  • Site master files
  • CPP/COPP issuance
  • Electronic CTD submissions

Advanced Manufacturing Ecosystem

Our facilities in Sarigam, Gujarat, India operate with:

  • Modern automation systems
  • High-volume manufacturing lines
  • WHO & PIC/S compliant cleanrooms
  • In-house microbiology laboratories
  • Advanced analytical labs
  • Stability testing facilities

Commercial Benefits for APAC Importers

  • Competitive pricing through large-scale production
  • Flexible MOQs
  • Long-term supply agreements
  • Private-label opportunities
  • In-licensing partnerships

Market Impact in the Bangladesh

The Philippines continues witnessing rapid growth in:

  • Cardiometabolic therapies
  • New-generation gastroenterology products
  • Chronic disease management formulations

Taj Medico’s strong dossier readiness and rapid regulatory turnaround make us a preferred partner for:

  • Pharmaceutical distributors
  • Hospitals
  • Government tenders
  • Procurement agencies